Exploring personalized neoadjuvant therapy selection strategies in breast cancer: an explainable multi-modal response modelResearch in context by Luyi Han, Tianyu Zhang, Anna D'Angelo, Anna van der Voort, Katja Pinker-Domenig, Marleen Kok, Gabe Sonke, Yuan Gao, Xin Wang, Chunyao Lu, Xinglong Liang, Jonas Teuwen, Tao Tan, Ritse Mann

Get full text

Five-year conditional relative survival up to 10 years post-diagnosis among adolescent and young adult breast cancer patients by age, stage, and receptor subtype by Noëlle J.M.C. Vrancken Peeters, Daniël J. van der Meer, Marleen Kok, Marissa C. van Maaren, Marie-Jeanne T.F.D. Vrancken Peeters, Sabine Siesling, Winette T.A. van der Graaf, Olga Husson

Get full text

SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapy by Evan J Lipson, Charlie Garnett-Benson, William L Redmond, Robert L Ferris, Marco Ruella, Mark Yarchoan, Kurt A Schalper, Daniela S Thommen, Marleen Kok, Ryan J Sullivan, Harriet M Kluger, Luca Paruzzo, Russell W Jenkins, Anthony R Cillo, Keith Tolley

Get full text

Neoadjuvant immune checkpoint blockade triggers persistent and systemic Treg activation which blunts therapeutic efficacy against metastatic spread of breast tumors by Olga S. Blomberg, Kevin Kos, Lorenzo Spagnuolo, Olga I. Isaeva, Hannah Garner, Max D. Wellenstein, Noor Bakker, Danique E.M. Duits, Kelly Kersten, Sjoerd Klarenbeek, Cheei-Sing Hau, Daphne Kaldenbach, Elisabeth A.M. Raeven, Kim Vrijland, Marleen Kok, Karin E. de Visser

Get full text